Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
63.62
-1.36 (-2.09%)
Nov 20, 2026, 4:00 PM EST - Market closed
Corcept Therapeutics Employees
Corcept Therapeutics had 730 employees as of December 31, 2025. The number of employees increased by 230 or 46.00% compared to the previous year. That makes Corcept Therapeutics the 17,179th largest employer in the world and 2,374th in the United States.
Employees
730
Change (1Y)
230
Growth (1Y)
46.00%
Revenue / Employee
$1,320,064
Profits / Employee
$218,305
Market Cap
6.96B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 730 | 230 | 46.00% | 730 | 0 |
| Dec 31, 2024 | 500 | 148 | 42.05% | 500 | 0 |
| Dec 31, 2023 | 352 | 53 | 17.73% | 352 | 0 |
| Dec 31, 2022 | 299 | 61 | 25.63% | 299 | 0 |
| Dec 31, 2021 | 238 | 2 | 0.85% | 238 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Axsome Therapeutics | 1,390 |
| Twist Bioscience | 1,080 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Mirum Pharmaceuticals | 470 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 315 |
| Protagonist Therapeutics | 149 |
CORT News
- 5 days ago - Corcept announces publication of case report on relacorilant plus nab-paclitaxel - TheFly
- 5 days ago - ESMO Rare Cancers Publishes Case Report Detailing Eight-Year Response to Relacorilant Plus Nab-Paclitaxel in Metastatic Vulvar Cancer - Business Wire
- 17 days ago - Corcept Therapeutics price target raised to $173 from $165 at Piper Sandler - TheFly
- 17 days ago - Corcept Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 17 days ago - Corcept Therapeutics Earnings release: Q3 2026 - Filings
- 17 days ago - Corcept Therapeutics Quarterly report: Q3 2026 - Filings
- 17 days ago - Corcept Therapeutics reports Q3 EPS $1.01, consensus 84c - TheFly
- 17 days ago - Corcept Therapeutics affirms FY26 revenue view $1.1B-$1.2B, consensus $1.15B - TheFly